HELSINN BIREX PHARMACEUTICALS LIMITED

Helsinn Birex Pharmaceuticals Limited is a global pharmaceutical company dedicated to supportive care for patients living with cancer and chronic diseases. Drawing on a unique integrated licensing model, Helsinn builds, launches and commercialises solid brands worldwide, ensuring that life-enhancing medicines reach those who need them through an extensive commercial and supply network.

The company's technical organisation combines internal expertise with external partnerships, covering everything from early-stage development and regulatory affairs to manufacturing and supply-chain management. Its state-of-the-art manufacturing plant in Ireland underpins both routine production and the creation of new products, turning strategic ideas into tangible, high-quality brands. Helsinn's portfolio focuses on products that improve patients' health and quality of life, reflecting core values of integrity, passion and quality.

Beyond its scientific endeavours, Helsinn is committed to responsible growth. The firm maintains carbon-neutral status, drives sustainability initiatives, and upholds the highest ethical standards, believing that societal impact and patient well-being are essential to long-term success.